125 related articles for article (PubMed ID: 7039044)
1. Effects of Corynebacterium parvum vaccine in conjunction with immunosuppression in renal transplant in dogs.
Munda R; Alexander JW; Stinnett JD; Weiss MA; Morris MJ
Transplantation; 1982 Mar; 33(3):333-5. PubMed ID: 7039044
[No Abstract] [Full Text] [Related]
2. [The use of Corynebacterium parvum in pleurodesis].
Helin T; Haahtela T
Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
[No Abstract] [Full Text] [Related]
3. The effects of Corynebacterium parvum in dogs and a study of its distribution following intravenous injection.
Owen LN; Lewis JC; Morgan DR; Gorman NT
Eur J Cancer (1965); 1980 Aug; 16(8):999-1005. PubMed ID: 6777166
[No Abstract] [Full Text] [Related]
4. Antitumor activity of Corynebacterium parvum.
Milas L; Scott MT
Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
[No Abstract] [Full Text] [Related]
5. Coparvax for malignant effusion?
Drug Ther Bull; 1983 Oct; 21(20):79-80. PubMed ID: 6641514
[No Abstract] [Full Text] [Related]
6. Immunotherapy of cancer with corynebacterium parvum.
Halpern B
Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
[No Abstract] [Full Text] [Related]
7. Macrophage activation and increased resistance to infection in immunosuppressed mice treated with Corynebacterium parvum vaccine or pyran copolymer.
Stinnett JD; Morris MJ; Alexander JW
J Reticuloendothel Soc; 1979 May; 25(5):525-31. PubMed ID: 458782
[No Abstract] [Full Text] [Related]
8. [Immunotherapy with Corynebacterium parvum in experimental influenza virus infections and mixed infections in mice].
Denys A; Kowalska M; Szydłowska T; Białek J
Pol Tyg Lek; 1986 May; 41(19):619-23. PubMed ID: 3763446
[No Abstract] [Full Text] [Related]
9. Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man.
Cederholm-Williams SA; King A; Allington MJ; Gill PG; Sharp AA; Britton BJ
Br J Cancer; 1978 Jun; 37(6):1074-7. PubMed ID: 678428
[No Abstract] [Full Text] [Related]
10. Improved survival in severely burned animals using intravenous Corynebacterium parvum vaccine post injury.
Stinnett JD; Alexander JW; Morris MJ; Dreffer RL; Craycraft TK; Anderson PE; Ogle CK; MacMillan BG
Surgery; 1981 Feb; 89(2):237-42. PubMed ID: 7455909
[TBL] [Abstract][Full Text] [Related]
11. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
Wolmark N; Levine M; Fisher B
J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
[No Abstract] [Full Text] [Related]
12. A phase-II trial of Corynebacterium parvum as adjuvant to surgery in the treatment of operable lung cancer.
Woodruff M; Walbaum P
Cancer Immunol Immunother; 1983; 16(2):114-6. PubMed ID: 6362846
[TBL] [Abstract][Full Text] [Related]
13. Modulation of macrophage functions by corynebacterium parvum preparations.
Bonina L; Delfino D; Costa GB; Arena A
Boll Ist Sieroter Milan; 1989; 68(1):62-6. PubMed ID: 2491287
[TBL] [Abstract][Full Text] [Related]
14. Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
Chocair PR; Duley JA; Cameron JS; Arap S; Ianhez L; Sabbaga E; Simmonds HA
Adv Exp Med Biol; 1994; 370():205-8. PubMed ID: 7660891
[No Abstract] [Full Text] [Related]
15. Canine migration inhibitory factor: effect of Corynebacterium parvum administration.
Pineiro MS; Bowles CA; Cutchins EC; Bull MI
Infect Immun; 1977 Oct; 18(1):102-9. PubMed ID: 332636
[TBL] [Abstract][Full Text] [Related]
16. Corynebacterium parvum and metastatic breast cancer.
Haskell CM; Sarna GP; Liu PY
Br J Cancer; 1982 May; 45(5):794-5. PubMed ID: 7044404
[No Abstract] [Full Text] [Related]
17. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
[TBL] [Abstract][Full Text] [Related]
18. Prolonged fever after pleural instillation of Corynebacterium parvum (Coparvax).
Laroche CM; Britton M
Thorax; 1987 Oct; 42(10):823-4. PubMed ID: 3424259
[No Abstract] [Full Text] [Related]
19. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
Motycka K; Chudomel V; Bednár M; Bostík J
Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
Kirchner H; Glaser M; Herberman R
Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
